Key facts
- This page summarizes Errol B. Desouza's Form 4 filing for CATALYST BIOSCIENCES, INC. (GYRE).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Oct 2021, 16:32.
Errol B. Desouza - 01 Oct 2021 Form 4 Insider Report for CATALYST BIOSCIENCES, INC. (GYRE)
- Reporting relationship
- Director
- Issuer ticker
- GYRE
- Reported as of
- 01 Oct 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Oct 2021, 16:32:07 UTC
- Prior SEC filing
- 29 Jun 2021
- Next SEC filing
- 16 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Seline Miller, Attorney-in-Fact for Errol B. DeSouza
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Errol B. Desouza filed Form 4 for CATALYST BIOSCIENCES, INC. (GYRE) on 05 Oct 2021.
Change
- Previous filing in this sequence was filed on 29 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CBIO
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +3,588
- Change %
- +14%
- Price
- $0.000000
- Shares after
- 29,801
- Date
- 01 Oct 2021
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents shares of common stock received in lieu of fees.